Document Detail


Thrombotic arteriopathy and anticoagulation in pulmonary hypertension.
MedLine Citation:
PMID:  16899857     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The role of thrombotic arteriopathy in the pathophysiology of idiopathic pulmonary arterial hypertension (IPAH) and the use of anticoagulants in the treatment of IPAH are currently controversial issues. This article reviews the evidence for a role of vascular thrombosis in the pathophysiology of IPAH. There is sufficient biological rationale to support the notion that thrombotic arteriopathy is an important pathophysiologic feature of pulmonary arterial hypertension (PAH) and that its progression materially contributes to disease progression. To date, the data from observational studies suggest that anticoagulation with warfarin is an effective intervention in patients with IPAH. Its efficacy in other causes of PAH remains speculative.
Authors:
Sindhu R Johnson; John T Granton; Sanjay Mehta
Related Documents :
17185187 - Technical advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hyp...
15679007 - Pulmonary haemodynamics in patients with osas or an overlap syndrome.
7376117 - Plexogenic pulmonary arteriopathy and liver cirrhosis.
12011667 - Recent advances in pulmonary vascular disease.
6724287 - A nervous connection between the hepatic plexus and right atrium in man.
12122277 - Disease patterns at arterial branches and their relation to flow.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Chest     Volume:  130     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-08-10     Completed Date:  2006-09-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  545-52     Citation Subset:  AIM; IM    
Affiliation:
Division of Rheumatology, University Health Network, University of Toronto, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / therapeutic use*
Disease Progression
Humans
Hypertension, Pulmonary / drug therapy,  etiology*
Pulmonary Artery*
Thromboembolism / complications*,  drug therapy
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mine...
Next Document:  Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective...